This new volume lays out the problem in detail, with specific recommendations to the federal government, the biotechnology and pharmaceutical industries, professional organizations, the health care industry, organized medicine, and the nation's universities and academic health centers.
The volume explores
- How clinical research is conducted, what human resources are available, and what research opportunities lie ahead.
- Why health professionals become discouraged about clinical research.
- How the educational system has failed in this area and what programs stand out as models.
- How funding affects the supply of researchers.